---
title: "The traditional Chinese medicine sector fluctuated and surged, with GZBL hitting the limit up"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261350598.md"
description: "The traditional Chinese medicine sector experienced a volatile rise, with GZBL hitting the limit up, and Weikang Pharmaceutical, Darentang, Fangsheng Pharmaceutical, Panlong Pharmaceutical, and Wohua Pharmaceutical following suit. In terms of related ETFs, the traditional Chinese medicine ETF had a transaction volume of 15.1552 million yuan. On October 15th, GZBL announced that its subsidiary \"Bailing Yuxiu Pharmaceutical Co., Ltd.\" has once again received the \"Drug Clinical Trial Approval Notice\" approved and issued by the National Medical Products Administration's Drug Evaluation Center, allowing the clinical trial of the traditional Chinese medicine Class 1 new drug Tangning Tongluo Tablets for the treatment of Type 2 diabetes"
datetime: "2025-10-16T01:45:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261350598.md)
  - [en](https://longbridge.com/en/news/261350598.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261350598.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/261350598.md) | [繁體中文](https://longbridge.com/zh-HK/news/261350598.md)


# The traditional Chinese medicine sector fluctuated and surged, with GZBL hitting the limit up

The traditional Chinese medicine sector experienced a volatile surge, with GZBL hitting the limit up, and Weikang Pharmaceutical, Darentang, Fangsheng Pharmaceutical, Panlong Pharmaceutical, and Wohua Pharmaceutical following suit. In terms of related ETFs, the traditional Chinese medicine ETF had a trading volume of 15.1552 million yuan. On October 15th, GZBL announced that its subsidiary, "Bailing Yuxiu Pharmaceutical Co., Ltd.," has once again received the "Drug Clinical Trial Approval Notice" approved and issued by the National Medical Products Administration's Drug Review Center, allowing the clinical trial of the traditional Chinese medicine Class 1 new drug, Tang Ning Tong Luo Pian, for the treatment of type 2 diabetes

### 相关股票

- [GZBL (002424.CN)](https://longbridge.com/zh-CN/quote/002424.CN.md)

## 相关资讯与研究

- [U.S. judge orders Trump administration to continue funding consumer watchdog agency](https://longbridge.com/zh-CN/news/279082198.md)
- [US must address issues with anti-drone laser system, senator says](https://longbridge.com/zh-CN/news/278871547.md)
- [10:30 ETInventHelp Inventor Develops Improved Design for a Toothbrush (OCC-1817)](https://longbridge.com/zh-CN/news/278740485.md)
- [Tidal Wave Auto Spa Celebrates Grand Opening in Mechanicsville with Free Washes](https://longbridge.com/zh-CN/news/278758925.md)
- [10:15 ETInventHelp Inventor Develops New Gift Wrap for Hanging Garments (SBT-2216)](https://longbridge.com/zh-CN/news/278900889.md)